We use cookies to personalise the web experience for you. By using www.helgilibrary.com, you agree to our use of cookies.
Some cookies are also used by Google Analytics, which anonymously tracks visitors and helps us to analyse how users use our website. Read more

Walmark

Pharmaceutical > Czech Republic > Walmark
Change Company
Walmark

Walmark is a Czech Republic-based producer of food supplements. The Company has been created at the beginning of 1990's as a greenfield investment. Nowadays, Walmark maintains its strong position in the Czech Republic, set up subsidiaries in seven other CEE markets and exports to further 30 countries in the world. Walmark's portfolio includes products such as Martians (multivitamins and multiminerals for childern), Spektrum (multivitamins

Read more »
Walmark is a Czech Republic-based producer of food supplements. The Company has been created at the beginning of 1990's as a greenfield investment. Nowadays, Walmark maintains its strong position in the Czech Republic, set up subsidiaries in seven other CEE markets and exports to further 30 countries in the world. Walmark's portfolio includes products such as Martians (multivitamins and multiminerals for childern), Spektrum (multivitamins and multiminerals for adults of all ages), ArthroStop (preparations for joint nutrition), GinkoPrim (herbal extract for better blood circulation), Prostenal, Urinal, or Dialevel, for example. In 2012, the Company achieved total sales of over CZK 2.1 bil and employed nearly 900 people

Buy all financials of Walmark

from $199 /month

Buy annual subscriptions for all our products.

summary Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

income statement

Sales CZK mil
Gross Profit CZK mil
EBIT CZK mil
Net Profit CZK mil
ROE %
EBIT Margin %
Net Margin %
Employees
                2,176 2,144 1,941 2,294 1,234    
                1,550 1,503 1,335 1,665 196    
                252 57.0 34.1 105 -328    
                214 -3.00 -8.61 41.8 -716    
                18.8% -0.377% -1.71% 6.40% -246%    
                11.6% 2.66% 1.76% 4.56% -26.6%    
                9.83% -0.140% -0.444% 1.82% -58.0%    
      ...         629 673 626 634 355    

balance sheet

                1,719 1,596 1,964 2,096 1,607    
                700 621 794 747 1,156    
                1,019 975 1,171 1,349 442    
                1,223 368 637 667 -85.0    
                496 1,228 1,327 1,429 1,692    
                37.0 833 768 693 0.000    
                558 395 559 735 1,629    
                0.471 4.81 4.37 2.26 -5.37    
                13.3% 195% 86.8% 73.0% -1,526%    
...               6.80% 7.39% 4.30% 5.04% 34.6%    

cash flow

                200 150 167 154 -349    
                -67.0 -39.0 -244 -71.2 -441    
                -126 -24.0 136 132 641    
                7.00 87.0 59.8 215 -150    

Download Data
income statement Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

income statement

Sales CZK mil
Cost of Goods & Services CZK mil
Gross Profit CZK mil
Staff Cost CZK mil
Other Cost CZK mil
EBITDA CZK mil
Depreciation CZK mil
EBIT CZK mil
Financing Cost CZK mil
Extraordinary Cost CZK mil
Pre-Tax Profit CZK mil
Tax CZK mil
Minorities CZK mil
Net Profit CZK mil
Dividends CZK mil
                2,176 2,144 1,941 2,294 1,234    
                626 641 606 629 1,038    
                1,550 1,503 1,335 1,665 196    
                346 373 367 428 230    
                858 981 841 1,022 207    
                346 149 126 215 -241    
                94.0 92.0 92.4 111 86.4    
                252 57.0 34.1 105 -328    
                17.0 38.0 35.6 42.8 397    
                0.000 0.000 0.000 0.000 0.000    
                235 19.0 -1.46 61.8 -725    
                21.0 22.0 7.15 20.0 -8.90    
                0.000 0.000 0.000 0.000 0.000    
                214 -3.00 -8.61 41.8 -716    
                660 ... 8.08 5.70 0.000   ...

growth rates

...               -8.22% -1.47% -9.47% 18.2% -46.2%    
...               -8.72% 12.5% -10.8% 20.0% -69.9%    
...               14.2% -56.9% -15.1% 70.2% -212%    
...               34.0% -77.4% -40.2% 207% -413%    
...               44.2% -91.9% -108% -4,319% -1,273%    
...               63.4% -101% 187% -585% -1,813%    

ratios

                18.8% -0.377% -1.71% 6.40% -246%    
...               16.0% -0.246% -0.742% 3.56% -56.9%    
                71.2% 70.1% 68.8% 72.6% 15.8%    
                15.9% 6.95% 6.52% 9.38% -19.6%    
                11.6% 2.66% 1.76% 4.56% -26.6%    
                9.83% -0.140% -0.444% 1.82% -58.0%    
                308% ... -93.7% 13.6% 0.000%   ...
...               6.80% 7.39% 4.30% 5.04% 34.6%    
                0.471 4.81 4.37 2.26 -5.37    

Download Data
balance sheet Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

balance sheet

                700 621 794 747 1,156    
                601 547 528 503 487    
                88.0 69.0 259 235 307    
... ...       ... ... ... ... ... ... ... ... ... ...
                1,019 975 1,171 1,349 442    
                377 290 305 316 171    
                598 553 516 539 154    
                32.0 116 267 391 116    
                1,719 1,596 1,964 2,096 1,607    
                1,223 368 637 667 -85.0    
                0.000 0.000 0.000 0.000 0.000    
                496 1,228 1,327 1,429 1,692    
                37.0 833 768 693 0.000    
                0.000 802 758 684 0.000    
                29.0 24.0 4.11 3.95 0.000    
                558 395 559 735 1,629    
                195 31.0 62.4 194 1,413    
                354 343 414 454 113    
                4.00 14.0 2.04 1.42 60.9    
                1,719 1,596 1,964 2,096 1,607    

growth rates

...               -2.00% -7.16% 23.1% 6.71% -23.3%    
...               15.5% -69.9% 73.1% 4.72% -113%    
...               -41.2% 340% -22.8% -12.0% 166%    
...               -36.1% 327% -1.50% 7.02% 61.0%    

ratios

                195 833 821 878 1,413    
                163 717 553 487 1,297    
                621 500 406 401 212    
                1,321 1,121 1,200 1,148 1,368    
                13.3% 195% 86.8% 73.0% -1,526%    
...               6.80% 7.39% 4.30% 5.04% 34.6%    

Download Data
cash flow Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

cash flow

                214 -3.00 -8.61 41.8 -716    
                94.0 92.0 92.4 111 86.4    
...               -93.0 -60.0 -10.2 -4.06 91.0    
...               -15.0 121 93.6 5.38 189    
                200 150 167 154 -349    
                -73.0 -40.0 -246 -75.5 -197    
                6.00 1.00 2.83 4.27 -244    
                -67.0 -39.0 -244 -71.2 -441    
                -660 ... -8.08 -5.70 0.000   ...
... ... ... ... ... ... ... ... ... ... ... -8.08 -5.70    
...               -110 638 -12.5 57.6 535    
                -126 -24.0 136 132 641    
                7.00 87.0 59.8 215 -150    

ratios

                100 94.1 97.0 85.8 45.6    
                220 165 184 183 60.2    
                206 195 249 264 39.8    
                114 64.0 31.2 5.58 66.0    
                308 89.0 83.7 152 -629    
                133 111 -76.5 82.6 -791    

Download Data
other data Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

other data

                12.3% -0.181% -0.484% 2.06% -38.7%    
                71.2% 70.1% 68.8% 72.6% 15.8%    
      ...         629 673 626 634 355    
      ...         2,592 2,361 2,499 2,630 2,261    
      ...         45,840 46,186 48,900 56,213 53,966    
                18.0% 17.9% 19.3% 19.5% 14.7%    
                8.94% 116% -488% 32.4% 1.23%    
                3.35% 1.87% 12.7% 3.29% 16.0%    
... ... ... ... ... ... ... ... ... ... ... ... 782    
... ... ... ... ... ... ... ... ... ... ... ... 63.4%    

Download Data

Walmark in Numbers

November 10, 2018
Walmark in Numbers

This Annual Statistical Dossier offers a summary of Walmark's performance between 2003 and 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

If you are only interested in

Read more »

This Annual Statistical Dossier offers a summary of Walmark's performance between 2003 and 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

If you are only interested in particular areas of the company's business, you can find and download specific indicators from the company's Corporate Profile, or specific charts from the company's Chart Section.

If you are interested in the company’s quarterly figures, please refer to the company’s Quarterly Statistical Dossier.

Walmark at a Glance

February 2, 2014
Walmark at a Glance

Walmark is a Czech Republic-based producer of food supplements. The Company has been created at the beginning of 1990's as a greenfield investment. Nowadays, Walmark maintains its strong position in the Czech Republic, set up subsidiaries in seven other CEE markets and exports to further 30 countries in the world. Walmark's portfolio includes products such

Read more »

Walmark is a Czech Republic-based producer of food supplements. The Company has been created at the beginning of 1990's as a greenfield investment. Nowadays, Walmark maintains its strong position in the Czech Republic, set up subsidiaries in seven other CEE markets and exports to further 30 countries in the world. Walmark's portfolio includes products such as Martians (multivitamins and multiminerals for childern), Spektrum (multivitamins and multiminerals for adults of all ages), ArthroStop (preparations for joint nutrition), GinkoPrim (herbal extract for better blood circulation), Prostenal, Urinal, or Dialevel, for example. In 2012, the Company achieved total sales of over CZK 2.1 bil and employed nearly 900 people.

This report offers a summary of the company's performance in 2003-2012. You will find here all the key numbers from the company's balance sheet, income statement and cash flow on the annual basis

Walmark in Numbers

January 31, 2014
Walmark in Numbers

Walmark is a Czech Republic-based producer of food supplements. The Company has been created at the beginning of 1990's as a greenfield investment. Nowadays, Walmark maintains its strong position in the Czech Republic, set up subsidiaries in seven other CEE markets and exports to further 30 countries in the world. Walmark's portfolio includes products such

Read more »

Walmark is a Czech Republic-based producer of food supplements. The Company has been created at the beginning of 1990's as a greenfield investment. Nowadays, Walmark maintains its strong position in the Czech Republic, set up subsidiaries in seven other CEE markets and exports to further 30 countries in the world. Walmark's portfolio includes products such as Martians (multivitamins and multiminerals for childern), Spektrum (multivitamins and multiminerals for adults of all ages), ArthroStop (preparations for joint nutrition), GinkoPrim (herbal extract for better blood circulation), Prostenal, Urinal, or Dialevel, for example. In 2012, the Company achieved total sales of over CZK 2.1 bil and employed nearly 900 people.

This excel file offers a summary of the company's performance in 2003-2012. You will find here all the key numbers from the company's balance sheet, income statement and cash flow on the annual basis in the local currency and in USD.

Walmark - Profits & Sales

November 10, 2018

Walmark made a net profit of CZK 124 mil in 2017, up 178% when compared to the last year. Total sales reached CZK 1,444 mil, which is up 14.8% when compared to the previous year.

Historically, the company’s net profit reached

Read more »

Walmark made a net profit of CZK 124 mil in 2017, up 178% when compared to the last year. Total sales reached CZK 1,444 mil, which is up 14.8% when compared to the previous year.

Historically, the company’s net profit reached an all time high of CZK 214 mil in 2011 and an all time low of CZK -716 mil in 2015.

In terms of sales, Walmark reached an all time high of CZK 2,997 mil in 2005 and an all time low of CZK 1,234 mil in 2015.

Walmark's net profit has grown nan% a year on average in the last five years while sales have increased by -7.60% a year since 2012.

The firm generated its shareholders an average return on invested capital of -11.2% in the last five years.

As far as Walmark's peers are concerned, Bayer Czech Republic posted a net profit and sales of CZK 106 mil and CZK 4,180 mil in 2017 and Amgen Czech Republic generated a net profit of CZK 37.8 mil (with sales of CZK 417 mil).

You can see all the company’s data at Walmark Profile, or you can download a report on the company in the report section.

Walmark - Profit Margins

November 10, 2018

Walmark made a net profit of CZK CZK 124 mil under revenues of CZK 1,444 mil in 2017, up 178% and 14.8%, respectively, when compared to the last year.

This translates into a net margin of 8.59%. Historically, the firm’s

Read more »

Walmark made a net profit of CZK CZK 124 mil under revenues of CZK 1,444 mil in 2017, up 178% and 14.8%, respectively, when compared to the last year.

This translates into a net margin of 8.59%. Historically, the firm’s net margin reached an all time high of 9.83% in 2011 and an all time low of -58.0% in 2015. The average net margin in the last five years amounted to -12.1%.

On the operating level, EBITDA margin reached 5.71% and EBIT amounted to 10.1% of sales in 2017.

As far as Walmark's peers are concerned, Bayer Czech Republic posted net and EBITDA margin of 2.53% and 3.77%, respectively in 2017 and Amgen Czech Republic generated margins of 9.06% and 11.8%.

You can see all the company’s data at Walmark Profile, or you can download a report on the company in the report section.

Walmark made a net profit of CZK 124 mil under revenues of CZK 1,444 mil in 2017, up 178% and 14.8%, respectively, when compared to the last year. This translates into a net margin of 8.59%.

Historically, the firm’s net

Read more »

Walmark made a net profit of CZK 124 mil under revenues of CZK 1,444 mil in 2017, up 178% and 14.8%, respectively, when compared to the last year. This translates into a net margin of 8.59%.

Historically, the firm’s net profit reached an all time high of CZK 214 mil in 2011 and an all time low of CZK -716 mil in 2015. Since 2012, the firm's net profit has increased 4236% or nan% a year on average.

On the operating level, EBITDA reached CZK 146 mil, up 534% when compared to the previous year. Over the last five years, company's EBITDA has grown -0.377% a year on average.

As far as Walmark's peers are concerned, Bayer Czech Republic posted net and EBITDA margin of 2.53% and 3.77%, respectively in 2017 and Amgen Czech Republic generated margins of 9.06% and 11.8%.

You can see all the company’s data at Walmark Profile, or you can download a report on the company in the report section.

Walmark - Indebtedness

November 10, 2018

Walmark's net debt reached CZK 1,089 mil and accounted for -773% of equity at the end of 2017. The ratio is down 45.6% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high

Read more »

Walmark's net debt reached CZK 1,089 mil and accounted for -773% of equity at the end of 2017. The ratio is down 45.6% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high of 195% in 2012 and an all time low of -1,526% in 2015.

When compared to EBITDA, net debt amounted to 7.44x at the end of the year. The ratio reached an all time high of 8.58 in 2008 and an all time low of -35.5 in 2016.

As far as Walmark's peers are concerned, Bayer Czech Republic posted net debt to equity of 94.4%x and 2.49x when compared to EBITDA at the end of 2017. Amgen Czech Republic ended the year 2017 with a net debt at -0.147%x of equity and -0.006x when compared to its EBITDA while Amgen Czech Republic had net debt at -0.147%x of equity and -0.006x to EBITDA at the end of the year.

You can see all the company’s data at Walmark Profile, or you can download a report on the company in the report section.

See all charts of the company »
Walmark's employees rose 1.94% to 316 in 2017
Walmark's net profit rose 178% to CZK 124 mil in 2017
Walmark's net profit rose 178% to CZK 124 mil in 2017
Walmark's Cash & Cash Equivalents rose 94.7% to CZK 306 mil in 2017
Walmark's Capital Expenditures rose 100% to CZK 60.7 mil in 2017
Walmark's Net Debt/EBITDA rose 121% to 7.44 in 2017
Walmark's Total Cash From Operations fell 62.2% to CZK 29.1 mil in 2017
Walmark's ROCE rose 186% to 10.9% in 2017
Walmark's Net Margin rose 168% to 8.59% in 2017